Intrinsic Value

The intrinsic value of Rede D'Or Sao Luiz SA (RDOR3) under the Base Case is 40.83 BRL per share. Compared with the current market price of 44.03 BRL, the stock appears Overvalued by 7% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

RDOR3 Intrinsic Value
R$40.83
Overvaluation 7%
Intrinsic Value
Price R$44.03

RDOR3 is valued in line with its history. A premium of this size has been typical over the past 5 years.

Monitor RDOR3
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value R$32.67
Get notified when the price drops into your buy zone
Current Price R$44.03
Intrinsic Value R$40.83
Margin of Safety 20% R$32.67
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to RDOR3

Fundamental Analysis

What Rede D'Or Sao Luiz Does

Health Care

Rede D'Or Sao Luiz is one of Brazil’s largest private healthcare groups. Its core business is running hospitals and related care centers that handle emergency care, surgeries, inpatient stays, and outpatient treatment. It also operates oncology and diagnostic services, so patients can move from testing to treatment within the same network.

Headquarters
Brazil BR
Employees
71 000
IPO date
Dec 10, 2020
Read the full company overview
View Company Overview

Rede D'Or Sao Luiz has no economic moat

No Moat Narrow Wide

Patients and health plans can choose competing hospitals, and rivals can add or acquire local capacity. Rede D'Or's size and recognition alone do not prevent alternatives from treating the same patients.

Read the full moat analysis
Financials
Efficiency

Earnings Waterfall
Rede D'Or Sao Luiz SA

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one RDOR3 stock?

The intrinsic value for Rede D'Or Sao Luiz SA (RDOR3) under the Base Case is 40.83 BRL.

Is RDOR3 stock undervalued or overvalued?

Compared with the current market price of 44.03 BRL, the stock appears Overvalued by 7% .

Back to Top